logo
Abu Dhabi Pioneers Collaborative Approach to Responsible AI in Healthcare at Health Leaders Roundtable

Abu Dhabi Pioneers Collaborative Approach to Responsible AI in Healthcare at Health Leaders Roundtable

Web Release24-04-2025
The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, convened senior international government officials at the Health Leaders Roundtable to shape a Declaration on AI governance principles for healthcare. Held on the sidelines of Abu Dhabi Global Health Week (ADGHW), it considered the challenges and opportunities in unlocking the potential of artificial intelligence (AI), and explored key principles in the governance of AI in healthcare.
Hosted together with PwC Middle East, findings from the roundtable will inform the development of a collaborative approach that will serve as a reference for governments, health systems, and innovators to ensure that AI's integration into healthcare systems is transparent, responsible, and inclusive.
His Excellency Mansoor Ibrahim Al Mansoori, Chairman of the Department of Health – Abu Dhabi, added: 'AI is not tomorrow's technology, it is today's reality. While many of us are adapting to its rise, our children will grow up with it as the norm. That's why the decisions we make today, around ethics, equity, and safety, must be made together. Through this declaration, we will establish a globally accessible guideline that extends beyond borders and commercial interests. This document is a call to action for governments, innovators, and healthcare leaders everywhere.'
The forthcoming Declaration on governance principles for AI in healthcare will outline guiding principles for responsible AI deployment to improve health outcomes and protect patient rights. Designed as a globally accessible resource, the declaration will inspire unified governance and serve as a trusted reference for stakeholders worldwide.
In her opening remarks at the Roundtable, Her Excellency Dr. Noura Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi, stated: 'AI has extraordinary potential in healthcare. It is already transforming how we deliver care, how we diagnose, and how we discover. But with great power comes great responsibility. In Abu Dhabi, we are harnessing AI as our engine and policy as our platform, turning data into life-saving insight, and insight into meaningful action. Our vision is to deliver healthcare that is precise, proactive, and personal and to do so in a way that puts people, not technology, at the centre.'
During the Roundtable, participants emphasised the need for agile legal and regulatory frameworks to enable the safe and ethical application of AI in healthcare, while enabling innovation. With an emphasis on the need for a human-centred approach, discussions explored key themes including standardisation of data, data privacy and trust, skills development and community engagement.
Key insights from the Roundtable highlight the need for:
Transparent testing frameworks to ensure AI tools meet real-world clinical standards;
Collaborative ecosystems that unite regulators, industry, academia, and civil society across geographies;
Responsible data access that protects privacy, ensure security, and clarify ownership;
Addressing the AI skills gap by scaling education and awareness across healthcare systems and prepare healthcare workforces for a new era.
Aligning AI use cases with real-world patient and system challenges, avoiding technology for technology's sake.
The Health Leaders Roundtable brought together a distinguished group of local and international voices, including government officials, AI experts, healthcare executives, and multilateral organisations, to explore the shared principles and practices needed to deploy AI responsibly, effectively, and equitably.
These themes build on Abu Dhabi's rapidly advancing AI ecosystem, which in the field of health, is taking billions of data points, and turning them into life-changing insights.
Supporting the Emirates's approach is the Global AI Healthcare Academy, launched by DoH, which equips healthcare professionals worldwide with theoretical knowledge and hands-on training needed to implement AI technologies effectively, setting a global standard for capacity building. In addition, Malaffi – the region's first Health Information Exchange – provides secure, real-time access to patient data across both public and private healthcare providers. This seamless data integration is crucial for enabling AI tools to be deployed safely, efficiently, and at scale.
ADGHW is a major government initiative from DoH, and serves as a platform for innovation and collaboration under the 2025 theme 'Towards Longevity: Redefining Health and Well-being.' By convening diverse stakeholders from around the world, ADGHW is a community without borders that seeks to advance the future of health and well-being.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Abu Dhabi launches newborn genetic testing programme
Abu Dhabi launches newborn genetic testing programme

TAG 91.1

timean hour ago

  • TAG 91.1

Abu Dhabi launches newborn genetic testing programme

Abu Dhabi has rolled out a newborn genetic screening programme for Emirati nationals across several hospitals, to enable early detection and diagnosis of genetic conditions. The Newborn Genetic Screening Programme offers whole genome sequencing to screen more than 815 treatable childhood genetic conditions, making it one of the most comprehensive genetic screening programmes for newborns in the world. Using genomics and artificial intelligence (AI), the first phase of the programme has been implemented as a voluntary option at Kanad Hospital and Danat Al Emarat Hospital, in partnership with M42. The initiative is planned to be expanded across all maternity hospitals to screen UAE Nationals and children of Emirati mothers born in the emirate, further strengthening Abu Dhabi's leadership in preventive healthcare and precision medicine. By collecting and testing cord blood samples at birth, with parental consent, healthcare providers can identify conditions that may not be apparent at birth but could significantly affect a child's health if treatment is delayed. The conditions screened under the programme include metabolic disorders, immunodeficiencies, hematologic conditions, and rare diseases such as spinal muscular atrophy, which is treatable by gene therapy. Results are reported within 21 days, and parents will receive genetic counselling and be referred to multidisciplinary specialists if any actionable findings are identified. Her Excellency Dr. Noura Khamis Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi, said: 'Healthcare begins long before symptoms appear, and today, empowered by science and technology, we can act earlier than ever before." Dr. Mohamed Al Ameri, Acting Director of Genome and Biobank Division, Department of Health – Abu Dhabi said: 'As we work to integrate genomics into our preventative healthcare infrastructure, we aim to expand this initiative to all maternity hospitals in the emirate, demonstrating how genomics can reshape healthcare, shifting from a one-size-fits-all model to a precise, proactive, and personalised approach that improves patient outcomes.' To support the rollout of the programme, DoH conducted a workshop to review the gene panel and patient journey with specialists from stakeholders across Abu Dhabi. DoH also collaborated with M42 to train 16 paediatricians and neonatologists across three maternity hospitals, Corniche Hospital, Danat Al Emarat and Kanad Hospital, on genetic counselling practices and the importance of newborn genetic screening. Early detection through this enhanced screening programme allows for timely medical intervention and aligns with Abu Dhabi's broader strategy to integrate genomics into various aspects of family health, including premarital screening and genetic counselling, thus creating a comprehensive, family-centred care ecosystem. These initiatives aim to reduce the prevalence of genetic diseases, inform reproductive choices, facilitate access to early intervention, and empower families with vital health information, fostering a future where personalised, preventative healthcare is the standard. The Newborn Genetic Screening Programme is one of several initiatives that have been made possible by the Emirati Genome Programme, such as the Premarital Screening Programme, harnessing the power of genomics and latest technologies to promote informed decisions. These efforts pave the way forward for more precise and effective treatments, ensuring the long-term health and wellbeing of future generations of Emiratis.

Department of Health – Abu Dhabi launches Newborn Genetic Screening Programme
Department of Health – Abu Dhabi launches Newborn Genetic Screening Programme

Al Etihad

time2 hours ago

  • Al Etihad

Department of Health – Abu Dhabi launches Newborn Genetic Screening Programme

18 Aug 2025 11:10 ABU DHABI (ALETIHAD)The Department of Health - Abu Dhabi (DoH), in alignment with the Emirati Genome Council's vision to realise a national shift towards personalised, precision healthcare, has launched the Newborn Genetic Screening Programme. The initiative translates Abu Dhabi's commitment to pioneering genomics-driven medicine that enables early detection and diagnosis, tailored interventions, and improved health outcomes for future Newborn Genetic Screening Programme offers whole genome sequencing to screen more than 815 treatable childhood genetic conditions, making it one of the most comprehensive genetic screening programmes for newborns the power of genomics and artificial intelligence (AI), the first phase of the programme has been implemented as a voluntary option at Kanad Hospital and Danat Al Emarat Hospital, in partnership with M42. The initiative is planned to be expanded across all maternity hospitals to screen UAE Nationals and children of Emirati mothers born in the emirate, further strengthening Abu Dhabi's leadership in preventive healthcare and precision collecting and testing cord blood samples at birth, with parental consent, healthcare providers can identify conditions that may not be apparent at birth but could significantly affect a child's health if treatment is delayed. The conditions screened under the programme include metabolic disorders, immunodeficiencies, hematologic conditions, and rare diseases such as spinal muscular atrophy, which is treatable by gene Noura Khamis Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi, said: 'Healthcare begins long before symptoms appear, and today, empowered by science and technology, we can act earlier than ever added: 'This programme reflects Abu Dhabi's commitment to leveraging innovation to serve our community, starting from the first days of life. Through early detection, personalised care, and strategic foresight, we are building a future of healthier generations and reinforcing Abu Dhabi's position as a global leader in proactive, precision healthcare.'Dr. Mohamed Al Ameri, Acting Director of Genome and Biobank Division, Department of Health – Abu Dhabi said: 'As we work to integrate genomics into our preventative healthcare infrastructure, we aim to expand this initiative to all maternity hospitals in the emirate, demonstrating how genomics can reshape healthcare, shifting from a one-size-fits-all model to a precise, proactive, and personalised approach that improves patient outcomes.'To support the rollout of the programme, DoH conducted a workshop to review the gene panel and patient journey with specialists from stakeholders across Abu also collaborated with M42 to train 16 paediatricians and neonatologists across three maternity hospitals, Corniche Hospital, Danat Al Emarat and Kanad Hospital, on genetic counselling practices and the importance of newborn genetic comprehensive workshops were conducted for obstetricians, midwives, nurses and technical teams from these are reported within 21 days, and parents will receive genetic counselling and be referred to multidisciplinary specialists if any actionable findings are detection through this enhanced screening programme allows for timely medical intervention and aligns with Abu Dhabi's broader strategy to integrate genomics into various aspects of family health, including premarital screening and genetic counselling, thus creating a comprehensive, family-centred care ecosystem. These initiatives aim to reduce the prevalence of genetic diseases, inform reproductive choices, facilitate access to early intervention, and empower families with vital health information, fostering a future where personalised, preventative healthcare is the standard. The Newborn Genetic Screening Programme is one of several initiatives that have been made possible by the Emirati Genome Programme, such as the Premarital Screening Programme, harnessing the power of genomics and the latest technologies to promote informed decisions. These efforts pave the way forward for more precise and effective treatments, ensuring the long-term health and well-being of future generations of Emiratis. Source: Aletihad - Abu Dhabi

Abu Dhabi launches newborn genetic screening to detect over 800 childhood conditions
Abu Dhabi launches newborn genetic screening to detect over 800 childhood conditions

Khaleej Times

time2 hours ago

  • Khaleej Times

Abu Dhabi launches newborn genetic screening to detect over 800 childhood conditions

The Department of Health – Abu Dhabi (DoH) announced on Monday (August 18) the launch of the Newborn Genetic Screening Programme—a major step toward personalised, precision healthcare. As one of the most comprehensive programmes of its kind globally, the initiative uses whole genome sequencing to screen newborns for over 815 treatable childhood genetic conditions. These include metabolic disorders, immunodeficiencies, blood disorders, and rare diseases such as spinal muscular atrophy — many of which can be managed or cured with early intervention. In the programme's initial phase, screening is being offered on a voluntary basis at Kanad Hospital and Danat Al Emarat Hospital, in partnership with M42. The service is available to UAE Nationals and children of Emirati mothers born in Abu Dhabi. Plans are already underway to expand the programme across all maternity hospitals in the emirate, further cementing Abu Dhabi's leadership in preventive medicine. This initiative is launched in collaboration with the Abu Dhabi Department of Health - Abu Dhabi and the Emirati Genome Council.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store